Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Autoimmune Disorders

  Free Subscription


23.03.2026

1 BMC Neurol
1 Brain
1 Curr Opin Immunol
2 Diabetes
1 Diabetes Res Clin Pract
3 Intern Med
3 J Clin Endocrinol Metab
1 J Immunol
1 J Nephrol
5 J Neurol
1 J Pediatr Endocrinol Metab
4 Kidney Int
2 Mult Scler
4 Neurology
4 PLoS One
3 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. ZHANG D, Wang Z, Ma W, Wang Z, et al
    Screening of signaling pathways and hub genes in Guillain-Barre syndrome based on bioinformatics and machine learning.
    BMC Neurol. 2026 Mar 13. doi: 10.1186/s12883-026-04766.
    PubMed        


    Brain

  2. LEAVITT VM
    Forget processing speed: cognitive changes in multiple sclerosis call for new measurement tools.
    Brain. 2026 Mar 16:awag107. doi: 10.1093.
    PubMed        


    Curr Opin Immunol

  3. RENAUDINEAU Y, Brooks W
    P2 purinergic receptors in systemic lupus erythematosus: from experimental findings to therapeutic perspectives.
    Curr Opin Immunol. 2026;100:102752.
    PubMed         Abstract available


    Diabetes

  4. RAINERI D, Savastio S, Bellone S, Scotti L, et al
    Memory Regulatory T Cells as a Biomarker of Early Type I Diabetes.
    Diabetes. 2026 Feb 23:db250161. doi: 10.2337/db25-0161.
    PubMed         Abstract available

  5. PUGLIESE A
    Distinct Host Responses to Enterovirus in Children With Islet Autoimmunity Provide a New Framework for the Role of Infections in Type 1 Diabetes.
    Diabetes. 2026;75:603-605.
    PubMed        


    Diabetes Res Clin Pract

  6. AL-ABDULRAZZAQ D, Lazinger S, Raicevic M, Simmons K, et al
    Global differences in thyroid autoimmunity and hypothyroidism among children with type 1 diabetes: data from the SWEET database.
    Diabetes Res Clin Pract. 2026 Mar 17:113215. doi: 10.1016/j.diabres.2026.113215.
    PubMed         Abstract available


    Intern Med

  7. KAWAKAMI E, Kamada Y, Fukui S, Jubashi T, et al
    Detection of Irpex lacteus in the Lung in a Case with Microscopic Polyangiitis-mimicking Manifestations Positive for Myeloperoxidase-antineutrophil Cytoplasmic Antibody.
    Intern Med. 2026;65:900-904.
    PubMed         Abstract available

  8. YAGUCHI H, Miyagawa S, Nakada R, Yamamoto S, et al
    Safe Childbirth in a Patient with Neuromyelitis Optica Spectrum Disorder Treated with Satralizumab.
    Intern Med. 2026;65:887-890.
    PubMed         Abstract available

  9. MAE H, Kanzaki G, Matsuo N, Ueda H, et al
    Relapse of Membranous Nephropathy Following Adrenalectomy for Cushing Syndrome: A Case Report.
    Intern Med. 2026 Mar 17. doi: 10.2169/internalmedicine.6888.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  10. CHEN NC, Shah VN, McQueen RB
    Time in Range and Incident Diabetic Retinopathy: Clinical and Economic Evidence from Real-World Type 1 Diabetes Care.
    J Clin Endocrinol Metab. 2025 Oct 4:dgaf544. doi: 10.1210.
    PubMed         Abstract available

  11. DENSON AM, Rodriguez KE, Letourneau-Freiberg LR, Kandasamy B, et al
    Children with Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA.
    J Clin Endocrinol Metab. 2025 Sep 27:dgaf473. doi: 10.1210.
    PubMed         Abstract available

  12. SALEH L, Schreurs MWJ, Boersma E, Drexhage HA, et al
    Maternal TSH-receptor antibodies predict fetal/neonatal hyperthyroidism in pregnancies with a history of Graves' disease.
    J Clin Endocrinol Metab. 2026 Mar 18:dgag118. doi: 10.1210.
    PubMed         Abstract available


    J Immunol

  13. YIN M, Hiam-Galvez KJ, Proekt I, Chan J, et al
    Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis.
    J Immunol. 2026;215:vkaf334.
    PubMed         Abstract available


    J Nephrol

  14. KRISHNA J, Khan Z, Chandra Y, Sivakumar S, et al
    Unveiling glomerulonephritis in the Pacific: a Fijian cohort study.
    J Nephrol. 2026 Mar 16:aajaf035. doi: 10.1093.
    PubMed         Abstract available


    J Neurol

  15. FUJII S, Yaguchi H, Kudo A, Eguchi K, et al
    Prevalence and profiles of clinically diagnosed autoimmune cerebellar ataxia in a Japanese nationwide survey.
    J Neurol. 2026;273:215.
    PubMed         Abstract available

  16. ZHANG X, Xiong X, Wei J, Yan Y, et al
    Real-world safety of satralizumab in neuromyelitis optica spectrum disorder: a FAERS-based risk stratification study.
    J Neurol. 2026;273:212.
    PubMed         Abstract available

  17. WIENDL H, Gold R, Pul R, Ernst M, et al
    Treatment-free remission in MS: long-term disease control with cladribine tablets.
    J Neurol. 2026;273:218.
    PubMed         Abstract available

  18. MISCIOSCIA A, Silvestri E, Puthenparampil M, Scialpi G, et al
    The cerebellar cognitive affective syndrome scale in early multiple sclerosis.
    J Neurol. 2026;273:219.
    PubMed         Abstract available

  19. CAO Z, Hou H, Liu H, Li B, et al
    Clinical characteristics of autoimmune GFAP astrocytopathy with concomitant Epstein-Barr virus positivity: a case series of 12 patients and literature review.
    J Neurol. 2026;273:221.
    PubMed         Abstract available


    J Pediatr Endocrinol Metab

  20. BAKJAJI S, Lahoti A, Hoffman RP, Mamilly L, et al
    The prevalence of autoimmune diseases in antibody negative type 1 diabetes mellitus.
    J Pediatr Endocrinol Metab. 2026 Mar 16. doi: 10.1515/jpem-2025-0705.
    PubMed         Abstract available


    Kidney Int

  21. LIU WB, Hu HK, Liu W, Rui HL, et al
    Anti-PLA2R1 IgG-mediated podocyte PLA2R1 cleavage drives glomerular subepithelial immune complex deposition in membranous nephropathy.
    Kidney Int. 2026 Mar 13:S0085-2538(26)00164-X. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available

  22. LI R, Ma Y, Xie X, Qin A, et al
    Evidence from multicenter clinical studies and humanized mouse models indicates that glomerular mesangial IgA2 deposition contributes to the pathogenesis of IgA nephropathy.
    Kidney Int. 2026 Mar 13:S0085-2538(26)00161-4. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available

  23. PATALE DN, Raju S, Ramesh A, P S P, et al
    Genitourinary tuberculosis in lupus nephritis.
    Kidney Int. 2026 Jan 29:S0085-2538(25)01034-8. doi: 10.1016/j.kint.2025.
    PubMed        

  24. QIN Z, Weiqiang L, Dajin C, Rending W, et al
    Empagliflozin-associated Armanni-Ebstein lesions in IgA nephropathy.
    Kidney Int. 2026 Mar 12:S0085-2538(26)00058-X. doi: 10.1016/j.kint.2025.
    PubMed        


    Mult Scler

  25. LANGER-GOULD AM, Smith JB, Nielsen AS, Beaber BE, et al
    De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy.
    Mult Scler. 2026 Mar 19:13524585261430130. doi: 10.1177/13524585261430130.
    PubMed         Abstract available

  26. GUERRERO-FERNANDEZ MM, Serrano-Alvarez C, Foronda-Bengoa J, Barrero-Hernandez FJ, et al
    Intrathecal synthesis of Epstein-Barr virus antibodies 15 years before onset of multiple sclerosis.
    Mult Scler. 2026 Mar 17:13524585261427398. doi: 10.1177/13524585261427398.
    PubMed         Abstract available


    Neurology

  27. ALFREDSSON L, Johansson E, Olsson T, Stridh P, et al
    Occupational Exposure to Industrial Dust and Rates of Multiple Sclerosis.
    Neurology. 2026;106:e214762.
    PubMed         Abstract available

  28. DESCHAMPS R, Papeix C, Demortiere S, Lardeux P, et al
    Frequency of AQP4 and MOG Antibodies in Patients With Optic Neuritis Fulfilling Minimal New Multiple Sclerosis MRI Criteria.
    Neurology. 2026;106:e214753.
    PubMed         Abstract available

  29. PEDERSON AM, Buto P, Zimmerman SC, Velez M, et al
    Type 1 Diabetes and Incident Dementia: An Analysis in the All of Us Cohort.
    Neurology. 2026;106:e214805.
    PubMed         Abstract available

  30. LEODORI G, Maccarrone D, Mancuso M, De Bartolo MI, et al
    Resting-State EEG Microstates as Dynamic Biomarkers of Network Dysfunction and Cognitive Impairment in Patients With Multiple Sclerosis.
    Neurology. 2026;106:e214778.
    PubMed         Abstract available


    PLoS One

  31. MIRMOSAYYEB O, Mohammadi I, Rajai Firouzabadi S, Vaheb S, et al
    Cognitive function is associated with risk of conversion to secondary progressive multiple sclerosis: A cross-sectional study.
    PLoS One. 2026;21:e0344558.
    PubMed         Abstract available

  32. SUN Y, Wei J, Zhao Y, Jiang X, et al
    GBP2 promotes podocyte pyroptosis and contributes to the pathogenesis of pediatric lupus nephritis.
    PLoS One. 2026;21:e0344601.
    PubMed         Abstract available

  33. LIU L, Jacobson B, Stefanovic D
    PID-controller enhanced artificial beta-cells.
    PLoS One. 2026;21:e0342799.
    PubMed         Abstract available

  34. NESBITT C, Rayner G, Timmens K, Kazzi C, et al
    Study protocol for a mixed methods convergent investigation of family domestic and sexual violence in multiple sclerosis and broader neurology in Australia.
    PLoS One. 2026;21:e0344667.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  35. ZURAWSKI J, Tuncer A, Profant MR, Wang J, et al
    ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: A human and experimental study.
    Proc Natl Acad Sci U S A. 2026;123:e2526147123.
    PubMed         Abstract available

  36. BEVIS AM, Rosa KJLH, Schwarting N, Cockerham TR, et al
    An autoimmunity-associated allele of PTPN22 enhances innate antiviral immunity to protect against acute coronavirus infection.
    Proc Natl Acad Sci U S A. 2026;123:e2519903123.
    PubMed         Abstract available

  37. HOU S, Lindholm PF, Thurman JM, Lee J, et al
    C4b-binding protein as an antigenic target in the pathogenesis of antiphosphatidylethanolamine autoantibodies.
    Proc Natl Acad Sci U S A. 2026;123:e2528183123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum